fx-imager Search Results


in vivo fx imager  (Kodak)
90
Kodak in vivo fx imager
In Vivo Fx Imager, supplied by Kodak, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/in vivo fx imager/product/Kodak
Average 90 stars, based on 1 article reviews
in vivo fx imager - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
fotoanalyst fx  (Fotodyne Inc)
90
Fotodyne Inc fotoanalyst fx
Fotoanalyst Fx, supplied by Fotodyne Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fotoanalyst fx/product/Fotodyne Inc
Average 90 stars, based on 1 article reviews
fotoanalyst fx - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
vivo ms fx pro optimal imaging system  (Bruker Corporation)
90
Bruker Corporation vivo ms fx pro optimal imaging system
Treatment with cCPEm neither opens the blood-brain barrier nor augments FUS +MB -mediated dextran leakage. Representative image of whole brains of treated mice and quantification of the fluorescence intensity for 10 kDa ( A,B ) and 70 kDa dextran ( C,D ) using the Bruker In <t>Vivo</t> MS FX <t>Pro</t> <t>optimal</t> <t>imaging</t> <t>system</t> (IVIS). No significant fluorescence intensity was observed for mice treated with cCPEm and the sham group. Pre-treatment with cCPEm at 20 mg/kg 2.5 hours prior to FUS +MB treatment did not significantly increase leakage of FD10 and TAMRA-D70 compared to FUS +MB alone (n≥4, each bar dot representing the average fluorescence intensity (avg radiant efficiency) obtained from one brain hemisphere, mean ± SEM; Two-way ANOVA with Tukey's multiple comparisons tests, ns: not significant, ✱ p <0.05 , ✱✱ p<0.01 and ✱✱✱ p <0.001).
Vivo Ms Fx Pro Optimal Imaging System, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vivo ms fx pro optimal imaging system/product/Bruker Corporation
Average 90 stars, based on 1 article reviews
vivo ms fx pro optimal imaging system - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
luminousfx imaging system  (Fotodyne Inc)
90
Fotodyne Inc luminousfx imaging system
Treatment with cCPEm neither opens the blood-brain barrier nor augments FUS +MB -mediated dextran leakage. Representative image of whole brains of treated mice and quantification of the fluorescence intensity for 10 kDa ( A,B ) and 70 kDa dextran ( C,D ) using the Bruker In <t>Vivo</t> MS FX <t>Pro</t> <t>optimal</t> <t>imaging</t> <t>system</t> (IVIS). No significant fluorescence intensity was observed for mice treated with cCPEm and the sham group. Pre-treatment with cCPEm at 20 mg/kg 2.5 hours prior to FUS +MB treatment did not significantly increase leakage of FD10 and TAMRA-D70 compared to FUS +MB alone (n≥4, each bar dot representing the average fluorescence intensity (avg radiant efficiency) obtained from one brain hemisphere, mean ± SEM; Two-way ANOVA with Tukey's multiple comparisons tests, ns: not significant, ✱ p <0.05 , ✱✱ p<0.01 and ✱✱✱ p <0.001).
Luminousfx Imaging System, supplied by Fotodyne Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luminousfx imaging system/product/Fotodyne Inc
Average 90 stars, based on 1 article reviews
luminousfx imaging system - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
kodak fx imager  (Carestream Health)
90
Carestream Health kodak fx imager
Treatment with cCPEm neither opens the blood-brain barrier nor augments FUS +MB -mediated dextran leakage. Representative image of whole brains of treated mice and quantification of the fluorescence intensity for 10 kDa ( A,B ) and 70 kDa dextran ( C,D ) using the Bruker In <t>Vivo</t> MS FX <t>Pro</t> <t>optimal</t> <t>imaging</t> <t>system</t> (IVIS). No significant fluorescence intensity was observed for mice treated with cCPEm and the sham group. Pre-treatment with cCPEm at 20 mg/kg 2.5 hours prior to FUS +MB treatment did not significantly increase leakage of FD10 and TAMRA-D70 compared to FUS +MB alone (n≥4, each bar dot representing the average fluorescence intensity (avg radiant efficiency) obtained from one brain hemisphere, mean ± SEM; Two-way ANOVA with Tukey's multiple comparisons tests, ns: not significant, ✱ p <0.05 , ✱✱ p<0.01 and ✱✱✱ p <0.001).
Kodak Fx Imager, supplied by Carestream Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kodak fx imager/product/Carestream Health
Average 90 stars, based on 1 article reviews
kodak fx imager - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Treatment with cCPEm neither opens the blood-brain barrier nor augments FUS +MB -mediated dextran leakage. Representative image of whole brains of treated mice and quantification of the fluorescence intensity for 10 kDa ( A,B ) and 70 kDa dextran ( C,D ) using the Bruker In Vivo MS FX Pro optimal imaging system (IVIS). No significant fluorescence intensity was observed for mice treated with cCPEm and the sham group. Pre-treatment with cCPEm at 20 mg/kg 2.5 hours prior to FUS +MB treatment did not significantly increase leakage of FD10 and TAMRA-D70 compared to FUS +MB alone (n≥4, each bar dot representing the average fluorescence intensity (avg radiant efficiency) obtained from one brain hemisphere, mean ± SEM; Two-way ANOVA with Tukey's multiple comparisons tests, ns: not significant, ✱ p <0.05 , ✱✱ p<0.01 and ✱✱✱ p <0.001).

Journal: Nanotheranostics

Article Title: Multimodal evaluation of blood-brain barrier opening in mice in response to low-intensity ultrasound and a claudin-5 binder

doi: 10.7150/ntno.95146

Figure Lengend Snippet: Treatment with cCPEm neither opens the blood-brain barrier nor augments FUS +MB -mediated dextran leakage. Representative image of whole brains of treated mice and quantification of the fluorescence intensity for 10 kDa ( A,B ) and 70 kDa dextran ( C,D ) using the Bruker In Vivo MS FX Pro optimal imaging system (IVIS). No significant fluorescence intensity was observed for mice treated with cCPEm and the sham group. Pre-treatment with cCPEm at 20 mg/kg 2.5 hours prior to FUS +MB treatment did not significantly increase leakage of FD10 and TAMRA-D70 compared to FUS +MB alone (n≥4, each bar dot representing the average fluorescence intensity (avg radiant efficiency) obtained from one brain hemisphere, mean ± SEM; Two-way ANOVA with Tukey's multiple comparisons tests, ns: not significant, ✱ p <0.05 , ✱✱ p<0.01 and ✱✱✱ p <0.001).

Article Snippet: The PBS-perfused mouse brains were then collected and immediately imaged in a Bruker In Vivo MS FX Pro optimal imaging system with a 480 or 540 excitation filter for detecting FD10 and a 540 or 570 nm emission filter for detecting TAMRA-D70, respectively.

Techniques: Fluorescence, In Vivo, Imaging